Maternal exposure to moderate ambient carbon monoxide is associated with decreased risk of preeclampsia

American Journal of Obstetrics and Gynecology

Volumn 207, Issue 1, 2012, Pages 57.e1-57.e9

  Zhai, Desheng ^a,b,c,d   Guo, Yanfang ^c,d   Smith, Graeme ^e   Krewski, Daniel ^c   Walker, Mark ^c,d   Wen, Shi Wu ^a,c,d  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b XINXIANG MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF OTTAWA   (Canada)

^d OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^e QUEEN S UNIVERSITY   (Canada)

Author keywords

carbon monoxide; environment; preeclampsia; socioeconomic status

Indexed keywords

CARBON MONOXIDE;

ADULT; AMBIENT AIR; ARTICLE; CANADA; CONFIDENCE INTERVAL; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; HUMAN; PREECLAMPSIA; PRIORITY JOURNAL; RISK; RISK ASSESSMENT;

EID: 84862638316     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2012.03.022     Document Type: Article

References (41)

1. Roberts JM, Lain KY. Recent Insights into the pathogenesis of pre-eclampsia. Placenta 2002;23:359-72.
2. Fruscalzo A, Bertozzi S, Londero AP, et al. Menstrual abnormalities and predisposition to pregnancy-related hypertensive disorders: a retrospective study. Gynecol Endocrinol 2010;26:445-50.
3. Zhang J, Meikle S, Trumble A. Severe maternal morbidity associated with hypertensive disorders in pregnancy in the United States. Hypertens Pregnancy 2003;22:203-12.
4. Wen SW, Smith G, Yang Q, Walker M. Epidemiology of preterm birth and neonatal outcome. Semin Fetal Neonatal Med 2004;9:429-35.
5. Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet 2008;371:75-84.
6. Liu A, Wen SW, Bottomley J, Walker MC, Smith G. Utilization of health care services of pregnant women complicated by preeclampsia in Ontario. Hypertens Pregnancy 2009;28:76-84.
7. Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ 2005;330:565.
8. Davisson RL, Hoffmann DS, Butz GM, et al. Discovery of a spontaneous genetic mouse model of preeclampsia. Hypertension 2002;39:337-42.
9. Higgins S. Smoking in pregnancy. Curr Opin Obstet Gynecol 2002;14:145-51.
10. England L, Zhang J. Smoking and risk of preeclampsia: a systematic review. Front Biosci 2007;12:2471-83.
11. Yang Q, Wen SW, Smith GN, et al. Maternal cigarette smoking and the risk of pregnancy-induced hypertension and eclampsia. Int J Epidemiol 2006;35:288-93.
12. Miller EC, Cao H, Wen SW, Yang Q, Lafleche J, Walker M. The risk of adverse pregnancy outcomes is increased in preeclamptic women who smoke compared with nonpreeclamptic women who do not smoke. Am J Obstet Gynecol 2010;203:334.e1-8.
13. Wikström AK, Stephansson O, Cnattingius S. Tobacco use during pregnancy and preeclampsia risk: effects of cigarette smoking and snuff. Hypertension 2010;55:1254-9.
14. Zhang J, Klebanoff MA, Levine RJ, Puri M, Moyer P. The puzzling association between smoking and hypertension during pregnancy. Am J Obstet Gynecol 1999;181:1407-13.
15. Bainbridge SA, Sidle EH, Smith GN. Direct placental effects of cigarette smoke protect women from pre-eclampsia: the specific roles of carbon monoxide and antioxidant systems in the placenta. Med Hypotheses 2005;64:17-27.
16. Karumanchi SA, Levine RJ. How does smoking reduce the risk of preeclampsia? Hypertension 2010;55:1100-1.
17. Brosens I, Pijnenborg R, Vercruysse L, Romero R. The "Great Obstetrical Syndromes" are associated with disorders of deep placentation. Am J Obstet Gynecol 2011;204:193-201.
18. Kahn SR, Almeida ND, McNamara H, et al. Smoking in preeclamptic women is associated with higher birthweight for gestational age and lower soluble fms-like tyrosine kinase-1 levels: a nested case control study. BMC Pregnancy Childbirth 2011;11:91.
19. El-Mousleh T, Casalis PA, Wollenberg I, et al. Exploring the potential of low doses carbon monoxide as therapy in pregnancy complications. Med Gas Res 2012;2:4.
20. Woodruff TJ, Morello-Frosch R, Jesdale B. Air pollution and preeclampsia among pregnant women in California, 1996-2004. Epidemiology 2008;19(suppl):S310.
21. Rich DQ, Demissie K, Lu SE, Kamat L, Wartenberg D, Rhoads GG. Ambient air pollutant concentrations during pregnancy and the risk of fetal growth restriction. J Epidemiol Community Health 2009;63:488-96.
22. Subramanian SV, Chen JT, Rehkopf DH, Waterman PD, Krieger N. Comparing individual- and area-based socioeconomic measures for the surveillance of health disparities: a multilevel analysis of Massachusetts births, 1989-1991. Am J Epidemiol 2006;164:823-34.
23. Kramer MS, Platt RW, Wen SW, et al. A new and improved population-based Canadian reference for birth weight for gestational age. Pediatrics 2001;108:E35.
24. Rothman KJ, Greenland S. Precision and validity in epidemiologic studies. In: Rothman KJ, Greenland S, eds. Modern epidemiology, 2nd ed. Philadelphia: Lippincott, Williams & Wilkins; 1998:133-4.
25. Xu H, Perez-Cuevas R, Xiong X, et al. An international trial of antioxidants in the prevention of preeclampsia (INTAPP). Am J Obstet Gynecol 2010;202:239.e1-10.
26. Rudra CB, Williams MA, Sheppard L, Koenig JQ, Schiff MA. Ambient carbon monoxide and fine particulate matter in relation to preeclampsia and preterm delivery in western Washington State. Environ Health Perspect 2011;119:886-92.
27. Sibai BM, Ewell M, Levine RJ, et al. Risk factors associated with preeclampsia in healthy nulliparous women: the Calcium for Preeclampsia Prevention (CPEP) study group. Am J Obstet Gynecol 1997;177:1003-10.
28. Rudra C, Williams M. A prospective study of periconceptional ambient air pollutant exposures and preeclampsia risk. Epidemiology 2006;17(suppl):S104-5.
29. Lindheimer MD, Taler SJ, Cunningham FG. Hypertension in pregnancy. J Am Soc Hypertens 2008;2:484-94.
30. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science 2005;308:1592-4.
31. Hladunewich M, Karumanchi SA, Lafayette R. Pathophysiology of the clinical manifestations of preeclampsia. Clin J Am Soc Nephrol 2007;2:543-9.
32. Baumann MU, Bersinger NA, Surbek DV. Serum markers for predicting pre-eclampsia. Mol Aspects Med 2007;28:227-44.
33. Mimura K, Tomimatsu T, Sharentuya N, et al. Nicotine restores endothelial dysfunction caused by excess sFlt1 and sEng in an in vitro model of preeclamptic vascular endothelium: a possible therapeutic role of nicotinic acetylcholine receptor (nAChR) agonists for preeclampsia. Am J Obstet Gynecol 2010;202:464.e1-6.
34. Li Volti G, Sacerdoti D, Sangras B, et al. Carbon monoxide signaling in promoting angiogenesis in human microvessel endothelial cells. Antioxid Redox Signal 2005;7:704-10.
35. Dulak J, Deshane J, Jozkowicz A, Agarwal A. Heme oxygenase-1 and carbon monoxide in vascular pathobiology: focus on angiogenesis. Circulation 2008;117:231-41.
36. Cudmore M, Ahmad S, Al-Ani B, et al. Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1. Circulation 2007;115:1789-97.
37. Wu L, Wang R. Carbon monoxide: endogenous production, physiological functions, and pharmacological applications. Pharmacol Rev 2005;57:585-630.
38. Bainbridge SA, Smith GN. HO in pregnancy. Free Radic Biol Med 2005;38:979-88.
39. Bainbridge SA, Farley AE, McLaughlin BE, et al. Carbon monoxide decreases perfusion pressure in isolated human placenta. Placenta 2002;23:563-9.
40. Bainbridge SA, Belkacemi L, Dickinson M, Graham CH, Smith GN. Carbon monoxide inhibits hypoxia/reoxygenation-induced apoptosis and secondary necrosis in syncytiotrophoblast. Am J Pathol 2006;169:774-83.
41. Kreiser D, Baum M, Seidman DS, et al. End tidal carbon monoxide levels are lower in women with gestational hypertension and preeclampsia. J Perinatol 2004;24:213-7.